» Authors » Eric Nerrienet

Eric Nerrienet

Explore the profile of Eric Nerrienet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 71
Citations 1634
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakotomalala F, Butel C, Rasamoelina T, Serrano L, Vidal N, Randriarimanana S, et al.
Infect Genet Evol . 2024 Oct; 125:105679. PMID: 39368593
Background And Objectives: Data on HIV drug resistance in Madagascar are rare and outdated. In this study, we assessed the prevalence of HIV drug resistance mutations to antiretrovirals (ARVs) and...
2.
Rakotomalala F, Bouillin J, Randriarimanana S, Thaurignac G, Maharavo L, Raberahona M, et al.
Viruses . 2023 Nov; 15(11). PMID: 38005934
To estimate the prevalence of IgG antibodies against six arboviruses in people living with HIV-1 (PLWHIV) in Madagascar, we tested samples collected between January 2018 and June 2021. We used...
3.
Pean P, Madec Y, Nerrienet E, Borand L, Laureillard D, Fernandez M, et al.
Pathogens . 2023 Oct; 12(10). PMID: 37887757
IRIS is a common complication in HIV-infected patients treated for tuberculosis (TB) and cART. Our aim was to evaluate NK cell reconstitution in HIV-infected patients with TB-IRIS compared to those...
4.
Segeral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, et al.
Front Public Health . 2018 Apr; 6:63. PMID: 29662875
Background: Assessment of virological outcomes among HIV-infected patients receiving protease (PR) inhibitor-based second-line regimen are uncommon in Cambodia. The objective of this study is to assess the virological effectiveness of...
5.
Sagaon-Teyssier L, Mmadi Mrenda B, Khol V, Ferradini L, Mam S, Ngin S, et al.
Trop Med Int Health . 2017 Sep; 22(11):1428-1435. PMID: 28905466
Objectives: To investigate whether adherence to antiretroviral treatment (ART) can be explained not only by individual factors but also by health care facilities' characteristics, among a sample of people living...
6.
Richard L, Mouinga-Ondeme A, Betsem E, Filippone C, Nerrienet E, Kazanji M, et al.
Clin Infect Dis . 2016 Jun; 63(6):800-803. PMID: 27325689
Molecular screening of 300 at-risk people from Central Africa identified 2 human T-lymphotropic virus (HTLV)-4-infected individuals. A zoonotic origin of infection was suggested, as both individuals reported being severely bitten...
7.
Ayouba A, Njouom R, Chia J, Ahuka-Mundeke S, Kfutwah A, Mpoudi Ngole E, et al.
Infect Genet Evol . 2014 Dec; 30:65-73. PMID: 25500294
African green monkeys (AGMs) represent the most widely distributed non-human primates species in Africa. SIVagm naturally infects four of the 6 AGMs species at high prevalence in a species-specific manner....
8.
Lavergne A, Donato D, Gessain A, Niphuis H, Nerrienet E, Verschoor E, et al.
J Virol . 2014 Sep; 88(22):13212-20. PMID: 25187544
Unlabelled: Primates are naturally infected with herpesviruses. During the last 15 years, the search for homologues of human herpesviruses in nonhuman primates allowed the identification of numerous viruses belonging to...
9.
Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, et al.
PLoS One . 2014 Mar; 9(3):e90350. PMID: 24608960
Objective: To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients. Methods: HIV-infected adults with CD4+ T cell...
10.
Borand L, Pheng P, Saman M, Leng C, Chea P, Ay S, et al.
Med Sci (Paris) . 2013 Oct; 29(10):908-11. PMID: 24148131
Tuberculosis is a major cause of death among adults infected by HIV. The CAMELIA (ANRS 1295/CIPRA KH001) randomized clinical trial aimed to determine the optimal timing of ARV initiation after...